These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 11063789

  • 21. Hormonal responses to meta-chlorophenylpiperazine (m-CPP) are undiminished by acute m-CPP pretreatment.
    Coccaro EF, Kavoussi RJ, Trestman RL, Gabriel SM, Cooper TB, Siever LJ.
    Psychiatry Res; 1996 May 17; 62(2):139-45. PubMed ID: 8771611
    [Abstract] [Full Text] [Related]

  • 22. Serotonergic and noradrenergic dysregulation in alcoholism: m-chlorophenylpiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects.
    Krystal JH, Webb E, Cooney NL, Kranzler HR, Southwick SW, Heninger GR, Charney DS.
    Am J Psychiatry; 1996 Jan 17; 153(1):83-92. PubMed ID: 8540598
    [Abstract] [Full Text] [Related]

  • 23. Altered neuroendocrine and behavioral responses to m-chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users.
    McCann UD, Eligulashvili V, Mertl M, Murphy DL, Ricaurte GA.
    Psychopharmacology (Berl); 1999 Nov 17; 147(1):56-65. PubMed ID: 10591869
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Increased psychological responses and divergent neuroendocrine responses to m-CPP and ipsapirone in patients with panic disorder.
    Broocks A, Bandelow B, George A, Jestrabeck C, Opitz M, Bartmann U, Gleiter CH, Meineke I, Roed IS, Rüther E, Hajak G.
    Int Clin Psychopharmacol; 2000 May 17; 15(3):153-61. PubMed ID: 10870873
    [Abstract] [Full Text] [Related]

  • 28. Low HDL cholesterol, aggression and altered central serotonergic activity.
    Buydens-Branchey L, Branchey M, Hudson J, Fergeson P.
    Psychiatry Res; 2000 Mar 06; 93(2):93-102. PubMed ID: 10725526
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effects of meta-chlorophenylpiperazine infusions in patients with seasonal affective disorder and healthy control subjects. Diurnal responses and nocturnal regulatory mechanisms.
    Schwartz PJ, Murphy DL, Wehr TA, Garcia-Borreguero D, Oren DA, Moul DE, Ozaki N, Snelbaker AJ, Rosenthal NE.
    Arch Gen Psychiatry; 1997 Apr 06; 54(4):375-85. PubMed ID: 9107154
    [Abstract] [Full Text] [Related]

  • 31. Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder.
    Pigott TA, Zohar J, Hill JL, Bernstein SE, Grover GN, Zohar-Kadouch RC, Murphy DL.
    Biol Psychiatry; 1991 Mar 01; 29(5):418-26. PubMed ID: 2018816
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Heterogeneity of serotonergic response in treatment-refractory schizophrenia patients.
    Lindenmayer JP, Adityanjee, Vital-Herne M, Bark N, Grochowski S, Moynihan N.
    Biol Psychiatry; 1997 Jul 01; 42(1):6-12. PubMed ID: 9193736
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Hormonal and subjective responses to intravenous m-chlorophenylpiperazine in women with seasonal affective disorder.
    Levitan RD, Kaplan AS, Brown GM, Vaccarino FJ, Kennedy SH, Levitt AJ, Joffe RT.
    Arch Gen Psychiatry; 1998 Mar 01; 55(3):244-9. PubMed ID: 9510218
    [Abstract] [Full Text] [Related]

  • 39. Behavioral, physiological and neuroendocrine responses in healthy volunteers to m-chlorophenylpiperazine (m-CPP) with and without ondansetron pretreatment.
    Broocks A, Briggs NC, Pigott TA, Hill JL, Canter SK, Tolliver TJ, Baldemore D, Murphy DL.
    Psychopharmacology (Berl); 1997 Mar 01; 130(2):91-103. PubMed ID: 9106905
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.